Table 1.
Organochlorines in adipose tissue from case and subcohort members.
| IQR (all; μg/kg lipid) | Above LOD [n (%)] | Median (5th–95th percentile; μg/kg lipid) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Compound | Cases | Subcohort | Cases | Subcohort | ||||||
| p,p´-DDT | 21 | 137 (57.3) | 137 (55.9) | 24 (9–83) | 21 (10–58) | |||||
| p,p´-DDE | 710 | 238 (99.6) | 237 (96.7) | 700 (180–2,400) | 640 (170–2,300) | |||||
| β-Hexachlorocyclohexane | 32 | 225 (94.1) | 220 (89.8) | 59 (31–110) | 56 (33–115) | |||||
| cis-Nonachlor | 4.7 | 155 (64.9) | 156 (63.7) | 8.1 (3.5–17.0) | 6.8 (3.1–16.0) | |||||
| trans-Nonachlor | 21 | 235 (98.3) | 232 (94.7) | 35 (17–76) | 32 (16–71) | |||||
| Oxychlordane | 14 | 169 (70.7) | 171 (69.8) | 26 (15–47) | 23 (12–45) | |||||
| Dieldrin | 16 | 140 (58.6) | 144 (59.0) | 24 (9–49) | 18 (8–49) | |||||
| Hexachlorobenzene | 35 | 204 (85.4) | 213 (86.9) | 54 (20–120) | 52 (19–110) | |||||
| PCB-118 | 23 | 233 (97.5) | 233 (95.1) | 34 (16–70) | 35 (17–72) | |||||
| PCB-156 | 13 | 235 (98.3) | 236 (96.3) | 34 (20–61) | 34 (21–57) | |||||
| PCB-99 | 16.5 | 171 (71.5) | 177 (72.2) | 28 (14–57) | 26 (12–53) | |||||
| PCB-138 | 80 | 238 (99.6) | 243 (99.2) | 150 (57–270) | 140 (66–260) | |||||
| PCB-153 | 130 | 239 (100.0) | 244 (99.6) | 300 (170–470) | 300 (160–510) | |||||
| PCB-170 | 43 | 238 (99.6) | 243 (99.2) | 100 (65–170) | 100 (68–170) | |||||
| PCB-180 | 70 | 239 (100.0) | 245 (100.0) | 200 (120–340) | 200 (130–320) | |||||
| PCB-183 | 12 | 226 (94.6) | 227 (92.7) | 25 (11–40) | 24 (12–47) | |||||
| PCB-187 | 22 | 238 (99.6) | 240 (98.0) | 58 (29–92) | 56 (30–99) | |||||
| PCB-201 | 8 | 224 (93.7) | 227 (92.7) | 19 (11–33) | 19 (11–31) | |||||